Dawn of the Bio-Century
Never before have we been in a better position to understand and combat human disease. Biotechnology has
evolved rapidly in the past three decades. And yet we remain an industry in its infancy, which means we have
only begun to realize the full potential of biotechnology and how it can benefit human health.
Many of the past century’s breakthrough innovations were in the areas of physics and information technology.
We believe we have entered an exciting new era—the Bio-Century—where there is great potential for new
discoveries as we gain a deeper understanding of human biology and biotechnology.
Major advances in DNA sequencing and gene therapy are leading to exciting opportunities in discovery
research. We also see growing global demand for biologic medicines on the horizon due to factors ranging
from greater access to healthcare to aging populations to new kinds of cancer treatments. And investments
are being made based on extensive knowledge of biologics manufacturing to improve existing processes and
technologies to help further optimize the outcomes we deliver to patients.
Amgen is well positioned to break new ground in our industry—at the dawn of the Bio-Century—and serve
more patients with our therapeutics worldwide